Sort
39,280 grants matching “leukemia”
Regulation of JAK/STAT pathways in the eye
$411,057Charles E Egwuagu · National Eye Institute · Z01 · FY2007 · EY
HIV-1 Preintegration Trafficking and Nuclear Localization
$411,033Alan N. Engelman · Dana-Farber Cancer Inst · R01 · FY2011 · AI
Characterization of SLE-Susceptability Loci on Mouse Chromosome 1
$410,878Laurence Morel · University Of Florida · R01 · FY2008 · AI
Targeted activation of autoimmune checkpoints in B cell malignancies
$410,875Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2018 · CA
Targeted activation of autoimmune checkpoints in B cell malignancies
$410,875Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2017 · CA
Targeted activation of autoimmune checkpoints in B cell malignancies
$410,875Markus Mãschen · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars
$410,850Charles J Dimitroff · Brigham And Women'S Hospital · R01 · FY2011 · AT
Myc-directed control of mRNA turnover in lymphopoiesis and lymphomagenesis
$410,850John L. Cleveland · Scripps Florida · R01 · FY2012 · CA
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars
$410,850Charles J Dimitroff · Brigham And Women'S Hospital · R01 · FY2010 · AT
Mechanistic Analysis of Anti-inflammatory Activity by Fluorosugars
$410,850Charles J Dimitroff · Brigham And Women'S Hospital · R01 · FY2012 · AT
Tyrosine Kinase inhibition: The New Front in HIV Cure Efforts
$410,850Vicente Planelles · University Of Utah · R01 · FY2022 · AI
Characterizing MSI2 in leukemia
$410,846Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Expanding the GoT toolkit to link single-cell clonal genotypes with protein, transcriptomic, epigenomic and spatial phenotypes
$410,790Dan Landau · Weill Medical Coll Of Cornell Univ · R33 · FY2023 · CA
RESIDUAL DISEASE DETECTION IN ALL USING FLOW CYTOMETRY
$410,724Johns Hopkins University · R01 · FY2002 · CA
Functional Genomic Dissection of Refractory Anemia
$410,702Benjamin Levine Ebert · Brigham And Women'S Hospital · R01 · FY2012 · HL
Development of small molecules targeting Ring1B-Bmi1 E3 ligase in leukemia
$410,649Tomasz Cierpicki · University Of Michigan At Ann Arbor · R01 · FY2017 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2020 · CA
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
$410,606Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2016 · CA
Metabolic pathways in leukemia
$410,606John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
$410,606Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Development of small molecules to target KDM4B
$410,606Jun Yang · St. Jude Children'S Research Hospital · R01 · FY2018 · CA
Pathway Specific Combinational Therapy in Poor Prognosis B-Lineage Acute Lymphoblastic Leukemia
$410,606Joseph T. Opferman · St. Jude Children'S Research Hospital · R01 · FY2017 · CA
Mediators Of Arrested Differentiation In Pediatric Rhabdomyosarcoma
$410,606Mark Edward Hatley · St. Jude Children'S Research Hospital · R01 · FY2021 · CA
Metabolic pathways in leukemia
$410,606John D Schuetz · St. Jude Children'S Research Hospital · R01 · FY2018 · CA